These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Necrotic ulcerations on the back of the hands in a patient with chronic renal failure: an uncommon presentation of calciphylaxis. Irazabal MP; Marques Martin L; Idoate Gastearena MÁ; Labiano Miravalles T; García Fernández N J Am Acad Dermatol; 2012 Oct; 67(4):e152-4. PubMed ID: 22980276 [No Abstract] [Full Text] [Related]
4. Calciphylaxis in dialysis patients, a severe disease poorly responding to therapies: report of 4 cases. Savoia F; Gaddoni G; Patrizi A; Misciali C; Odorici G; Tampieri G; Tampieri E; Cantelli S; Aldi M G Ital Dermatol Venereol; 2013 Oct; 148(5):531-6. PubMed ID: 24005147 [TBL] [Abstract][Full Text] [Related]
5. Atypical calciphylaxis in a patient receiving warfarin then resolving with cessation of warfarin and application of hyperbaric oxygen therapy. Banerjee C; Woller SC; Holm JR; Stevens SM; Lahey MJ Clin Appl Thromb Hemost; 2010 Jun; 16(3):345-50. PubMed ID: 20019019 [TBL] [Abstract][Full Text] [Related]
6. Warfarin-induced skin necrosis progressing to calciphylaxis. Breakey W; Hall C; Vann Jones S; Husain A; Kernohan M J Plast Reconstr Aesthet Surg; 2014 Oct; 67(10):e244-6. PubMed ID: 24953291 [No Abstract] [Full Text] [Related]
7. Calciphylaxis in a diabetic patient provoked by warfarin therapy. Asobie N; Wong E; Cook MG Clin Exp Dermatol; 2008 May; 33(3):342-4. PubMed ID: 18419610 [No Abstract] [Full Text] [Related]
8. Warfarin-induced calciphylaxis in a chronic hypercalcemic patient. Huang YC; Chou CY; Sue YM; Hu CH Indian J Dermatol Venereol Leprol; 2013; 79(1):135. PubMed ID: 23254751 [No Abstract] [Full Text] [Related]
12. Non-uremic Calciphylaxis: A Rare and Late Adverse Reaction of Warfarin. Patel DM; Patel MV; Patel AD; Kaklotar JC; Patel GR; Patel MM Curr Drug Saf; 2019; 14(3):246-248. PubMed ID: 30834840 [TBL] [Abstract][Full Text] [Related]
13. Spontaneous cutaneous ulcers in a patient with a moderate degree of chronic kidney disease: a different spectrum of calciphylaxis. Hitti WA; Papadimitriou JC; Bartlett S; Wali RK Scand J Urol Nephrol; 2008; 42(2):181-3. PubMed ID: 17853048 [TBL] [Abstract][Full Text] [Related]
14. Evaluating the validity of subclassifying warfarin-associated nonuremic calciphylaxis: a retrospective cohort study. Lehman JS; Chen TY; Lohse CM; El-Azhary RA Int J Dermatol; 2018 May; 57(5):572-574. PubMed ID: 29336027 [TBL] [Abstract][Full Text] [Related]